Georgia CTSA Newsletter
|
Trouble viewing this email? View on the web.
| |
|  | 
Georgia CTSA
Weekly eRoundup
July 10, 2020
|
| |
| | | | | Congratulations to Jessica Shantha, MD, Assistant Professor, Section of Vitreoretinal Surgery and Diseases and Section of Uveitis and Vasculitis, Emory Eye Center, and Georgia Clinical & Translational Science Alliance (Georgia CTSA) Master in Science in Clinical Research (MSCR) trainee who is the recipient of the American Academy of Ophthalmology’s 2020 Artemis Award. This award recognizes a young ophthalmologist Academy member who has demonstrated ... | | | | Read More | | |
|
| |
| | | | | | The NIH has launched a centralized, secure enclave to store and study vast amounts of medical record data from people diagnosed with coronavirus disease across the country. It is part of an effort, called the National COVID Cohort Collaborative (N3C), to help scientists analyze these data to understand the disease and develop treatments. This effort aims to transform clinical information into knowledge urgently needed to study COVID-19. | | | | Learn More | | |
|
| |
| | | | A Certificate of Confidentiality (CoC) supplements existing privacy safeguards of subjects by limiting the disclosure of identifiable, sensitive research data. The CoC protects data release due to compulsory legal demands (i.e., court orders or subpoenas) with identifying information or characteristics of research subjects. CoC's are granted by NIH for all NIH research and are also available by application for non-NIH-funded studies gathering identifiable, sensitive data. Examples of such information include but are not limited to demographics, fingerprints, voiceprints, photographs, genetic information, tissue samples, or data fields that when used in combination with other information may lead to identification of an individual. See Emory IRB for more details. | | | | Read More | | |
| |
| | | | A team of Emory + Morehouse investigators are preparing a P50 Intellectual and Developmental Disabilities Research Center (IDDRC). We seek partners from throughout a regional academic pediatric healthcare system that includes Children’s Healthcare of Atlanta, Emory Pediatrics, Public Health, Nursing and Yerkes, and Morehouse Pediatrics. The purpose of this survey is to build community and identify funded investigators and those researchers interested in participating in the growth of this new center. If funded, the E+M IDDRC will leverage unique institutional resources in the areas of genetics and genomics, model systems, computational neuroscience and bioinformatics, early brain and behavioral health, bioethics, health services and implementation & dissemination research, and community engagement/participatory research. Please contact Mike Zwick at mzwick@emory.edu if you have any questions. | | | | Read More | | |
| |
| | | | The Woodruff Health Sciences Center (WHSC) announces the launch of the WHSC COVID-19 CENTER for URGENT RESEARCH ENGAGEMENT (COVID-19 CURE) and Awards Program, made possible by generous philanthropic support from the O. Wayne Rollins Foundation and the William Randolph Hearst Foundation. The CURE Center was created to facilitate high-impact science and discovery towards improved COVID-19 treatment and prevention research. The goal is to invest in high-impact Emory projects (e.g. in diagnostics, immunology, therapeutics, vaccines, seroprevalence, cohort development, disparities, computational studies and other clinical research) and smaller exploratory projects that can change the clinical course (effectively treat/prevent serious disease) or prevent the transmission and spread of this infection. The funds can be used to support new COVID-19 focused researchers, equipment/instrumentation, technical support, pilots and enhancing facilities for this work. In addition, COVID-19 CURE will act as a hub, facilitating and helping to prioritize Emory COVID-19 research activities. http://georgiactsa.org/documents/news/COVID-19-CURE.pdf. | | | | Read More | | |
| |
| | | | NIH has launched a four-pronged initiative, entitled Rapid Acceleration of Diagnostics, or RADx, to catalyze the scientific community to improve testing technologies, capacity, and accessibility for the country. As one of the four RADx components, RADx-Underserved Populations (RADx-UP) will establish a network of community-engaged projects to improve access to and acceptance of testing in underserved and vulnerable populations. The overarching goal of this $500M effort is to understand factors that have led to disproportionate burden of the pandemic on these populations, so that interventions can be implemented to decrease the disparities. Applications for this first phase will be accepted through August 2020 for FY20 funding. A second phase will be staggered to provide flexibility and to allow for adaption to the ever-changing needs that may be present as this pandemic evolves. Visit www.nih.gov/RADx to learn more. | | | | Read More | | |
| |
| | | | The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of-Care Technology Research Network (POCTRN). NIBIB will support the full range of product development including commercialization and product distribution. | | | | Read More | | |
| |
| | | | NIAID issued two funding opportunity announcements (FOAs) to support research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). The two FOAs are ideal for applicants proposing new coronavirus-related research projects. The scope and nature of your proposed research project should guide your decision whether to apply through the R01 or R21 FOA. They feature rolling submission, meaning you can apply as soon as it is ready and NIAID will review it in an expedited fashion. | | | | Read More | | |
| |
| | | | For up-to-date NIH COVID-19 information, including: Informational Videos; Proposal Submission & Award Management Resources; Human Subjects & Clinical Trials Guidance; Animal Welfare; Frequently Asked Questions regarding flexibilities for grantees and; Funding Opportunities, please visit the link below. | | | | Read More | | |
| |
| | | | Lever for Change will award a single $10 million grant for a project that will measurably reduce greenhouse gas emissions in in the buildings, industry, and/or transportation sectors in the U.S. by 2030. Emory University will provide significant institutional support for up to three, individual research proposals that will be chosen and identified as the official Emory institutional submissions. Support will include: institutional endorsement; proposal development assistance; video production assistance; budget guidance; and other resources that will facilitate the creation of the strongest possible submissions. For questions, please contact Kristin Anderson at kristin.anderson@emory.edu. | | | | Read More | | |
| |
| | | | The purpose of this Funding Opportunity Announcement (FOA) is to support the establishment of multidisciplinary Tuberculosis (TB) Research Units (TBRUs) that will operate as a collaborative network to improve understanding of Mycobacterium tuberculosis (Mtb)-host interactions through characterization of bacterial and host determinants that are relevant during stages of infection and disease, and analyses of bacterial and host heterogeneity on disease outcomes. Applicants may propose a recommended budget of up to $1.8 million per year in direct costs. The maximum project period is 5 years. Please contact Holly Sommers at hsomme2@emory.edu for questions. | | | | Read More | | |
| |
| | | | Keck funds innovative, high-risk, and high-impact projects that are top institutional priorities. Keck projects solve important science and engineering questions and also develop novel techniques or instruments that can be disseminated throughout the research community. Award is up to one million. Both Senior and Early Career investigators are encouraged to apply. Keck does not, however, fund translational biomedical research. Keck seeks to fund projects that do not fit within established federal agency funding schema. Emory may ultimately submit two (2) Phase I proposals, 1 in Medical Research, and 1 in Science & Engineering by the November 1, 2020 deadline. Please contact Kristin Anderson at kristin.anderson@emory.edu for questions. | | | | Read More | | |
| |
| | | | The Chan Zuckerberg Initiative invites applications for five-year grants to support the work of Imaging Scientists employed in imaging core facilities at non-profit universities or research institutes across the world. The initiative seeks to support the work of up to 15 Imaging Scientists who will work at the interface of biology, microscopy hardware, and imaging software at imaging core facilities across the world. The primary goal of the program is to increase interactions between biologists and technology experts. The maximum budget that can be requested is $250,000 total costs per year for five years (no more than $1,250,000 total for five years). The award period is three years plus an additional two years, awarded as a separate grant, if the Imaging Program passes a review at year three. Please contact Connor Cook (Connor.Cook@emory.edu) if you have any questions or to inform of your intent to submit. | | | | Read More | | |
| |
| | | | The PATH award provides $500,000 over five years to support accomplished investigators at the assistant professor level to study pathogenesis, with a focus on the interplay between human and microbial biology, shedding light on how human and microbial systems are affected by their encounters. | | | | Read More | | |
| |
| | | | This Funding Opportunity Announcement (FOA) supports applications for Claude D. Pepper Older Americans Independence Centers (OAICs), centers of excellence in geriatrics research and research education, to increase scientific knowledge leading to better ways to maintain or restore independence in older persons. The OAIC awards are designed to develop or strengthen awardee institutions’ programs that focus on and sustain progress in a key area in aging research related to the mission of the OAIC program. Annual direct costs are limited to $950,000. The maximum project period is 5 years. Please contact Holly Sommers at hsomme2@emory.edu for questions. | | | | Read More | | |
| |
| | | | This $4 Million Prize elevates the compelling stories of community members and leaders across the country who are working together to transform neighborhoods, schools, businesses, and more so that the opportunity for better health flourishes for all. Contact Connor Cook at Connor.Cook@emory.edu if you have any questions. | | | | Read More | | |
| |
| | | | The Harry Frank Guggenheim Foundation welcomes proposals from any of the natural and social sciences and the humanities that promise to increase understanding of the causes, manifestations, and control of violence and aggression. The Foundation provides both research grants to established scholars and dissertation fellowships to graduate students during the dissertation-writing year. Highest priority is given to research that can increase understanding and amelioration of urgent problems of violence and aggression in the modern world. Most awards fall within the range of $15,000 to $40,000 per year for periods of one or two years. Please contact your RAS unit and Nicole Dancz (Nicole.dancz@emory.edu) to inform of your intent to submit. | | | | Read More | | |
| |
| | | | The Chan Zuckerberg Initiative invites applications for open source software projects that are essential to biomedical research. Applicants can request funding between $50k and $250k for one year (inclusive of up to 15% for indirect/overhead costs). | | | | Read More | | |
| |
| | | | Proposal deadline has been extended in consideration of the challenges facing many in our country. The Faculty Early Career Development (CAREER) Program is a foundation-wide activity that offers the National Science Foundation's most prestigious awards in support of early-career faculty who have the potential to serve as academic role models in research and education and to lead advances in the mission of their department or organization. NSF encourages proposals from early-career faculty at all CAREER-eligible organizations and especially encourages women, members of underrepresented minority groups, and persons with disabilities to apply. | | | | Read More | | |
| |
| | | | With the aim of speeding up development, testing and dissemination of evidence-based interventions for MCI, the Innovation Accelerator (IA) core is offering seed grants to support research in the following areas: therapeutic programming, technology and the built environment. The funded projects should result in innovative solutions, strategies or methodologies developed through a culture of collaboration among students, researchers, clinicians and people with MCI in less than 12 months’ time. Proposals can range from semester to year-long research projects and smaller proposals can target funds to convene valuable discussions, gather data, develop methods and metrics or to prototype new designs and technologies. For questions, email Kimberly Bass Seaton at kimberly.seaton@design.gatech.edu. | | | | Read More | | |
| |
| | | | The National Cancer Institute (NCI) announces an opportunity for current NCI funded Principal Investigators whose postdoctoral fellows have temporarily lost stipend support from a non-profit funder because of the COVID-19 global pandemic may apply for an administrative supplement to cover the postdoctoral fellow’s salary plus applicable F&A for the time and effort devoted to the NCI funded grant. Please contact Tiffany Worboy (tworboy@emory.edu) if you have any questions. | | | | Read More | | |
| |
| | | | The purpose of this Funding Opportunity Announcement (FOA) is to address the problem of HIV persistence in people living with HIV treated with suppressive antiretroviral drug regimens. The application must include at least one private sector entity to facilitate rapid translation of basic discovery research into therapeutic development and testing. Collaboratory research should be milestone-based and should be focused on specific innovative approaches to characterize and quantify persistent HIV-1 reservoirs and/or understand and predict post-treatment control of viral rebound, identify and test therapeutic strategies to control viral rebound after discontinuation of antiretroviral therapy, and identify and test strategies to eradicate or permanently inactivate rebound-competent HIV. Application budgets are limited to $3.5 million direct costs per year and should reflect the actual needs of the proposed project. The total project period must be 5 years. Please contact Holly Sommers at hsomme2@emory.edu for questions. | | | | Read More | | |
| |
| | | | This Funding Opportunity Announcement (FOA) is soliciting applications to support research on HIV cure in pediatric populations. This FOA will support coordinated basic, clinical, and applied research focused on developing strategies to achieve an HIV cure, defined as either sustained viral remission or eradication of HIV infection. This funding opportunity will target perinatally infected children and adolescents and young adults up to 24 years of age with a primary focus on early treated children. Application budgets are limited to $3.5 million direct costs per year and should reflect the actual needs of the proposed project. The total project period must be 5 years. Please contact Holly Sommers at hsomme2@emory.edu for questions. | | | | Read More | | |
| |
| | | | The goal of this $1 Million funding opportunity is to translate and adapt knowledge from around the world to the United States on approaches that can improve health or the determinants of health by improving gender equity. Contact Connor Cook at Connor.Cook@emory.edu if you have any questions. | | | | Read More | | |
| |
| | | | CASI provides $500,000 over five years to bridge advanced postdoctoral training and the first three years of faculty service. These grants are intended to foster the early career development of researchers who have transitioned or are transitioning from undergraduate and/or graduate work in the physical/mathematical/computational sciences or engineering into postdoctoral work in the biological sciences, and who are dedicated to pursuing a career in academic research. Please contact Tiffany Worboy (tworboy@emory.edu) if you have any questions. | | | | Read More | | |
| |
| | | | Robert Wood Johnson Foundation seeks proposals that are primed to influence health equity in the future. We are interested in ideas that address any of these four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work. Additionally, we welcome ideas that might fall outside of these four focus areas, but which offer unique approaches to advancing health equity and our progress toward a Culture of Health. | | | | Read More | | |
| |
| | | | The Association of Black Cardiologists, Inc. (ABC) is pleased to announce the Dr. Richard Allen Williams Scholarship for African American and other minority 1st or 2nd year medical students who show promise in medical research, cardiology and academic medicine. Two $5,000 scholarships will be awarded to recipients in honor of Dr. Richard Allen Williams. Winners will be announced by September 25, 2020. | | | | Read More | | |
| |
| | | | The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research. Application budgets are limited to a maximum of $250,000 direct cost per year and must reflect the actual needs of the proposed project. The maximum project period is 5 years. Please contact Holly Sommers at hsomme2@emory.edu for questions. | | | | Read More | | |
| |
| | | | The new Georgia CTSA Grant Wise service offers the opportunity for one-on-one feedback from experienced senior faculty on grant writing. We are soliciting experienced faculty to serve as volunteer mentors. If you have experience in writing grants and you enjoy mentoring, we need you! After completing the online volunteer form, we will be in touch should we receive a request that matches your expertise. Contact lauren.james@emory.edu | | | | Volunteer Form | | |
| |
| | | | The COVID-19 Collaboration Platform brings unassociated research teams working on the same clinical research questions together to share protocols, data, and evidence. COVID-19 Collaboration Platform offers support managing collaborations, including expedited and prioritized help from the Trial Innovation Network and SMART IRB to form multi-site trials; expert statistical advice for aggregated analyses, and free data storage and anonymization through vivli.org. | | | | Read More | | |
| |
| | | | The National Center for Data to Health and NCATS are leading the creation of a national, centralized, secure portal for COVID-19 clinical data. The cloud-based collaborative portal will allow for the development of machine learning and other informatics tools that require a large row-level dataset and will be overseen by a data access committee. This portal will provide additional assets needed to rapidly develop the analytics that clinical centers and physicians need now. | | | | Read More | | |
| |
| | | | CURE ID is an internet-based repository that lets the clinical community report novel uses of existing drugs for difficult-to-treat infectious diseases through a website, a smartphone or other mobile device. The platform enables the crowdsourcing of medical information from health care providers to guide potentially life-saving interventions and facilitate the development of new treatments for neglected diseases. CURE ID is a collaboration between the FDA and the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH). | | | | Read More | | |
| |
| | | | Georgia CTSA is now offering Virtual Studios to meet your research brainstorming needs. Our on-site presence has temporarily changed, but our desire to help you plan and collaborate regarding existing and potential research has not paused. Examples of areas where we have served past customers with expert brainstorming include locating collaborators and resources, hypothesis generation, study design, implementation, analysis and interpretation, translation and manuscript development of research topics. Contact the Georgia CTSA Coordinating Center by emailing Karen Lindsley at klindsl@emory.edu or Submit a Request for a Studio Consultation. | | | | Submit a Request | | |
| |
| | | | What's the answer to your "I wish I had..." or, "What if we could...?" when it comes to your ideas for novel medical device technology? What if you could partner alongside and advise a Georgia Tech Biomedical Engineering (BME) team to investigate and develop a solution for that idea in just 16 weeks? You can! BME Capstone is currently seeking project proposals for the Fall 2020 semester. During GT BME Capstone, each Capstone team works over 500 manhours per project to ideate, design, and prototype real solutions that address unmet clinical needs. If you have identified a health-care challenge that needs to be solved, Capstone teams are eager to work on it. | | | | Read More | | |
| |
| |  | | The Georgia CTSA recently partnered with the All of Us Research Program. All of Us is a health research program funded by the National Institutes of Health (NIH). Its goal is to help researchers better understand why people get sick or stay healthy. The mission of the All of Us Research Program is simple: to speed up health research and medical breakthroughs. To do this, All of Us is asking one million people from across the U.S. to share their health ... | | | | Read More | | |
| |
| | | | Join us virtually from 12:00 PM – 1:00 PM with Morgan Nicholls, MSN, RN, Clinical Research Nurse, Children’s Healthcare of Atlanta to learn more about best practices for infection control in the research setting. | | | | Read More | | |
| |
| | | | The DOM will host a Town Hall discussion for research faculty, staff, and trainees to provide a moderated, safe, and brave forum to discuss the impact of the many recent instances of racism and violence against people of color. We invite you to join us and to share how these challenging situations have impacted your work and personal lives, address where support is needed, and begin the process of planning action step recommendations for the department. We welcome you to take this time to share your perspective during these difficult times. Participants will be divided into breakout rooms led by a team of diversity dialogue co-facilitators to encourage and guide meaningful conversations. | | | | Register | | |
| |
| | | | Join us virtually from 12:00 PM – 1:00 PM with panelists Patrice Harris, MD; Carlos Del Rio, MD; Susan S. Margulies, PhD; and Charles E. Moore, MD, FAACE for an inclusive leadership discussion. All faculty and staff are welcome! | | | | Register | | |
| |
| | | | Mark your calendar and join us in 2021 as we bring together researchers from across the region to present the best new clinical and translational research and build collaborative partnerships. More information, registration, and call for abstracts will be announced in the coming months. We are closely monitoring the COVID-19 pandemic and will make a decision later this year whether to proceed virtually or in person at Callaway Resort & Gardens. | | | | Read More | | |
| |
| For more information on Georgia Clinical & Translational Science Alliance (Georgia CTSA), please visit
www.GeorgiaCTSA.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to
GeorgiaCTSA@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email
GeorgiaCTSA@emory.edu.
Please include the following citation in any publications resulting from direct or indirect Georgia CTSA support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002378. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2TR002381 and TL1 Trainees should also list TL1TR002382. |
| |
|
